People affected by human immunodeficiency virus (HIV), which causes AIDS, did not develop more severe forms of mpox than HIV-negative people during the multiregional outbreak of this disease that occurred in Spain in 2022. ...
Mar 11, 2026
0
4
While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only about 20% consistently used condoms and just half of the study participants ...
Mar 9, 2026
0
5
How people with compromised immune systems respond to vaccines is an important area of immunological research. A study led by York University has found that not only could machine-learning models accurately pinpoint differences ...
Mar 4, 2026
0
9
Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can expect long, full lives. But as patients age, a new reality has emerged: The biggest threats to their ...
Mar 4, 2026
0
4
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in persons with human immunodeficiency virus (HIV) and medication adherence challenges, according to a ...
Feb 27, 2026
0
17
A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the 2025 freeze on U.S. foreign assistance triggered disruptions to HIV services, medications, labs, ...
Feb 25, 2026
0
7
By pairing digital tools with tailored HIV services delivered by community health workers and clinicians, a study has reduced new HIV cases by 70% in rural Kenya and Uganda. This successful strategic implementation of existing ...
Feb 24, 2026
0
22
As new infectious threats emerge worldwide, a key U.S. health agency is quietly stepping away from language tied to pandemic planning, a change some experts warn could leave Americans less protected when the next crisis hits.
Feb 18, 2026
0
6
Utilizing data from Stichting HIV monitoring (SHM) and Statistics Netherlands, a study published in the journal Nature Communications has compared labor market outcomes of 5,960 people diagnosed with HIV between 2010 and ...
Feb 16, 2026
1
8
Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for the potential of widespread ...
Feb 9, 2026
0
18
